1. NCPDP Participates in White House Opioid Summit

    A three-hour summit is taking place at the White House today, to discuss the steps taken to address the opioid crisis since the president declared the epidemic a public health emergency in October.  NCPDP’s Senior Vice President of Public Policy and Industry Relations, Steve Mullenix, R.Ph., received an invitation and is attending the event.

    Read More

  2. Are You Compliant with CMS 455 Pharmacy Disclosure and Credentialing Requirements?

    NCPDP’s resQ™ Pharmacy Credentialing Resource can help reduce time and resources needed to achieve compliance.

    Read More

  3. NCPDP’s John Klimek to Present at 5th Biennial Biosimilars & Biobetters Congress in London

    John Klimek, R.Ph., Senior VP, Standards and Information Technology, NCPDP, will present, Biosimilars Non-Proprietary Naming – Help Patient Safety Or Confusion?” at the 5th Biennial Biosimilars & Biobetters Congress, April 16-17, 2018, in London.

    Read More

  4. Keeping NCPDP Standards Values and Definitions Current Is Critical

    Did you know failure to update NCPDP Standards’ values and definitions can result in rejected claims and creates errors in the systems requiring extensive research and manual adjustments?

    Read More

  5. Get the Prescriber Data Top PBMs and Payers Trust Most

    With 14 million+ modifications1 made annually to prescriber data, healthcare organizations find it hard to keep up as well as lack confidence in the accuracy of their data.  So, why rely on outdated data and waste time and money if there is a better solution?

    Read More

For problems with the site please contact us at webmaster@ncpdp.org